US Stock MarketDetailed Quotes

Eloxx Pharmaceuticals (ELOX)

Watchlist

0.1750
+0.1729+8233.33%

15min DelayClose May 15 15:44 ET

1.33MMarket Cap-1.46P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Eloxx Pharmaceuticals (ELOX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-552.91%-5.45M

-34.19%-6.33M

1.2M

67.12%-4.72M

54.97%-14.34M

-2.01M

50.33%-3.45M

78.80%-2.07M

28.21%-6.81M

9.02%-31.85M

Net income from continuing operations

-119.66%-3.75M

-90.74%-6M

---1.71M

81.57%-3.14M

52.71%-17.05M

---2.89M

52.16%-3.59M

59.12%-4.34M

46.39%-6.23M

45.95%-36.07M

Operating gains losses

----

-242.42%-1.33M

----

72.11%-389K

-3,200.00%-1.4M

---1.32M

-890.00%-495K

103.85%4K

55.19%419K

109.87%45K

Depreciation and amortization

----

--0

----

-79.73%164K

16.40%809K

--250K

-0.53%188K

42.31%185K

-6.06%186K

-27.60%695K

Other non cash items

-118.77%-49K

-47.65%245K

--261K

-4.49%468K

-9.43%490K

--42K

102.16%281K

-64.93%47K

-3.23%120K

-97.55%541K

Change In working capital

-164.44%-1.7M

122.07%520K

--2.63M

-379.15%-2.36M

815.25%844K

--1.57M

41.86%-250K

4,430.30%1.43M

-409.92%-1.91M

-268.75%-118K

-Change in receivables

--0

200.00%2.36M

--2.36M

---2.36M

--0

----

-Change in prepaid assets

-4,697.22%-1.66M

-748.08%-337K

--36K

-88.87%52K

85.32%467K

--441K

-51.76%206K

-50.44%397K

50.64%-577K

-56.70%252K

-Change in payables and accrued expense

-132.80%-41K

-521.09%-1.86M

--125K

-59.50%441K

346.31%1.09M

--1.31M

59.77%-278K

265.62%1.21M

-158.96%-1.16M

13.49%244K

-Change in other current liabilities

----

96.95%-4K

----

81.60%-131K

-15.96%-712K

---183K

-7.23%-178K

-70.19%-177K

0.57%-174K

25.93%-614K

-Change in other working capital

----

200.00%359K

--112K

---359K

----

Cash from discontinued investing activities

Operating cash flow

-552.91%-5.45M

-34.19%-6.33M

--1.2M

67.12%-4.72M

54.97%-14.34M

---2.01M

50.33%-3.45M

78.80%-2.07M

28.21%-6.81M

9.02%-31.85M

Investing cash flow

Cash flow from continuing investing activities

-97.37%1K

-87.70%38K

568.18%309K

51K

585.42%233K

300.00%14K

200.00%11K

-103.21%-66K

Net PPE purchase and sale

----

-97.37%1K

----

-87.70%38K

568.18%309K

--51K

585.42%233K

300.00%14K

200.00%11K

25.84%-66K

Net business purchase and sale

----

--0

Cash from discontinued investing activities

Investing cash flow

----

-97.37%1K

----

-87.70%38K

568.18%309K

--51K

585.42%233K

300.00%14K

200.00%11K

-103.21%-66K

Financing cash flow

Cash flow from continuing financing activities

912.83%7.03M

219.89%11M

-865K

184.25%3.44M

-146.32%-4.08M

-1.68M

144.67%3.67M

1.43M

-207.14%-7.5M

-82.65%8.81M

Net issuance payments of debt

--0

-47.35%1.61M

---865K

132.53%3.06M

---9.4M

---1.68M

---220K

--0

---7.5M

--0

Net common stock issuance

----

--0

----

--0

--4.89M

--1K

--3.46M

----

--0

Proceeds from stock option exercised by employees

--7.03M

--9.69M

--0

----

--0

Net other financing activities

----

-178.74%-300K

----

-11.60%381K

-95.11%431K

--0

----

244.76%8.81M

Cash from discontinued financing activities

Financing cash flow

912.83%7.03M

219.89%11M

---865K

184.25%3.44M

-146.32%-4.08M

---1.68M

144.67%3.67M

--1.43M

-207.14%-7.5M

-82.65%8.81M

Net cash flow

Beginning cash position

4,030.17%4.79M

-91.43%116K

--116K

-93.04%1.35M

-54.27%19.47M

--4.99M

-85.02%4.54M

-87.11%5.17M

-54.27%19.47M

72.17%42.57M

Current changes in cash

365.49%1.58M

477.63%4.68M

--339K

93.17%-1.24M

21.58%-18.11M

---3.64M

108.25%453K

93.60%-624K

-471.66%-14.3M

-229.46%-23.1M

End cash Position

1,299.78%6.37M

4,030.17%4.79M

--455K

-91.43%116K

-93.04%1.35M

--1.35M

-79.88%4.99M

-85.02%4.54M

-87.11%5.17M

-54.27%19.47M

Free cash flow

-552.91%-5.45M

-34.19%-6.33M

--1.2M

67.12%-4.72M

55.06%-14.34M

---2.01M

50.67%-3.45M

78.82%-2.07M

28.29%-6.81M

9.06%-31.91M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-552.91%-5.45M	-34.19%-6.33M	1.2M	67.12%-4.72M	54.97%-14.34M	-2.01M	50.33%-3.45M	78.80%-2.07M	28.21%-6.81M	9.02%-31.85M
Net income from continuing operations	-119.66%-3.75M	-90.74%-6M	---1.71M	81.57%-3.14M	52.71%-17.05M	---2.89M	52.16%-3.59M	59.12%-4.34M	46.39%-6.23M	45.95%-36.07M
Operating gains losses	----	-242.42%-1.33M	----	72.11%-389K	-3,200.00%-1.4M	---1.32M	-890.00%-495K	103.85%4K	55.19%419K	109.87%45K
Depreciation and amortization	----	--0	----	-79.73%164K	16.40%809K	--250K	-0.53%188K	42.31%185K	-6.06%186K	-27.60%695K
Other non cash items	-118.77%-49K	-47.65%245K	--261K	-4.49%468K	-9.43%490K	--42K	102.16%281K	-64.93%47K	-3.23%120K	-97.55%541K
Change In working capital	-164.44%-1.7M	122.07%520K	--2.63M	-379.15%-2.36M	815.25%844K	--1.57M	41.86%-250K	4,430.30%1.43M	-409.92%-1.91M	-268.75%-118K
-Change in receivables	--0	200.00%2.36M	--2.36M	---2.36M	--0	----	----	----	----	----
-Change in prepaid assets	-4,697.22%-1.66M	-748.08%-337K	--36K	-88.87%52K	85.32%467K	--441K	-51.76%206K	-50.44%397K	50.64%-577K	-56.70%252K
-Change in payables and accrued expense	-132.80%-41K	-521.09%-1.86M	--125K	-59.50%441K	346.31%1.09M	--1.31M	59.77%-278K	265.62%1.21M	-158.96%-1.16M	13.49%244K
-Change in other current liabilities	----	96.95%-4K	----	81.60%-131K	-15.96%-712K	---183K	-7.23%-178K	-70.19%-177K	0.57%-174K	25.93%-614K
-Change in other working capital	----	200.00%359K	--112K	---359K	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-552.91%-5.45M	-34.19%-6.33M	--1.2M	67.12%-4.72M	54.97%-14.34M	---2.01M	50.33%-3.45M	78.80%-2.07M	28.21%-6.81M	9.02%-31.85M
Investing cash flow
Cash flow from continuing investing activities		-97.37%1K		-87.70%38K	568.18%309K	51K	585.42%233K	300.00%14K	200.00%11K	-103.21%-66K
Net PPE purchase and sale	----	-97.37%1K	----	-87.70%38K	568.18%309K	--51K	585.42%233K	300.00%14K	200.00%11K	25.84%-66K
Net business purchase and sale	----	----	----	----	----	----	----	----	----	--0
Cash from discontinued investing activities
Investing cash flow	----	-97.37%1K	----	-87.70%38K	568.18%309K	--51K	585.42%233K	300.00%14K	200.00%11K	-103.21%-66K
Financing cash flow
Cash flow from continuing financing activities	912.83%7.03M	219.89%11M	-865K	184.25%3.44M	-146.32%-4.08M	-1.68M	144.67%3.67M	1.43M	-207.14%-7.5M	-82.65%8.81M
Net issuance payments of debt	--0	-47.35%1.61M	---865K	132.53%3.06M	---9.4M	---1.68M	---220K	--0	---7.5M	--0
Net common stock issuance	----	--0	----	--0	--4.89M	--1K	--3.46M	----	----	--0
Proceeds from stock option exercised by employees	--7.03M	--9.69M	--0	--0	--0	----	----	----	----	--0
Net other financing activities	----	-178.74%-300K	----	-11.60%381K	-95.11%431K	--0	----	----	----	244.76%8.81M
Cash from discontinued financing activities
Financing cash flow	912.83%7.03M	219.89%11M	---865K	184.25%3.44M	-146.32%-4.08M	---1.68M	144.67%3.67M	--1.43M	-207.14%-7.5M	-82.65%8.81M
Net cash flow
Beginning cash position	4,030.17%4.79M	-91.43%116K	--116K	-93.04%1.35M	-54.27%19.47M	--4.99M	-85.02%4.54M	-87.11%5.17M	-54.27%19.47M	72.17%42.57M
Current changes in cash	365.49%1.58M	477.63%4.68M	--339K	93.17%-1.24M	21.58%-18.11M	---3.64M	108.25%453K	93.60%-624K	-471.66%-14.3M	-229.46%-23.1M
End cash Position	1,299.78%6.37M	4,030.17%4.79M	--455K	-91.43%116K	-93.04%1.35M	--1.35M	-79.88%4.99M	-85.02%4.54M	-87.11%5.17M	-54.27%19.47M
Free cash flow	-552.91%-5.45M	-34.19%-6.33M	--1.2M	67.12%-4.72M	55.06%-14.34M	---2.01M	50.67%-3.45M	78.82%-2.07M	28.29%-6.81M	9.06%-31.91M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm